SCHEMBL5556515

SCHEMBL5556515

Cc1ccc(-c2ncccc2C#N)cc1N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.47
▸ TBK1 Q9UHD2 3/20 0.45
▸ SLC2A2 P11168 1/20 0.44
▸ PDE4D Q08499 1/20 0.43
▸ XDH P47989 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ CDC42BPB Q9Y5S2 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ PDK1 Q15118 3/20 0.41
▸ PDK2 Q15119 3/20 0.41
▸ PDK3 Q15120 3/20 0.41
▸ PDK4 Q16654 3/20 0.41
▸ P2RX3 P56373 1/20 0.41
▸ P2RX2 Q9UBL9 1/20 0.41
▸ KCNMA1 Q12791 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ RAF1 P04049 2/20 0.39
▸ BRAF P15056 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672439 0.80 GAA (0.41) MAPK1RAF1BRAF
SCHEMBL11341892 0.71 PRKDC (0.53) HTTL3MBTL1
SCHEMBL30449208 0.71 ALDH1A1 (0.60) KCNMA1L3MBTL1
SCHEMBL3357016 0.71 ALDH1A1 (0.60) KCNMA1L3MBTL1
SCHEMBL7675508 0.69 TRPV1 (0.50) CNR2
SCHEMBL10094652 0.69 GAA (0.55) CNR2MAPK1HTT
SCHEMBL13123271 0.69 PDE3B (0.47) TBK1XDHROCK2ROCK1CDC42BPB
SCHEMBL140064 0.69 KDM4E (0.58) ROCK2ROCK1CDC42BPBMAPK1HTT
SCHEMBL30748520 0.69 KDM4E (0.58) ROCK2ROCK1CDC42BPBMAPK1HTT
SCHEMBL2084217 0.69 ALDH1A1 (0.51) PDE4DROCK2ROCK1CDC42BPBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656351-B1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-12-19 — — EP claimed
EP-1656351-A1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-05-17 — — EP claimed
WO-2005014549-A1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES F. HOFFMANN-LA-ROCHE AG (CH) 2005-02-17 — — WO claimed
US-20050014792-A1 Process for preparation of pyridine derivatives ROCHE PALO ALTO LLC 2005-01-20 — — US claimed
EP-1656351-B1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-12-19 — — EP disclosed
US-7288658-B2 Process for preparation of pyridine derivatives HOFFMANN-LA ROCHE INC. (US) 2007-10-30 — — US disclosed
EP-1656351-A1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-05-17 — — EP disclosed
WO-2005014549-A1 PROCESS FOR PREPARATION OF 4-ARYL-NICOTINAMIDE DERIVATIVES F. HOFFMANN-LA-ROCHE AG (CH) 2005-02-17 — — WO disclosed
US-20050014792-A1 Process for preparation of pyridine derivatives ROCHE PALO ALTO LLC 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014792-A1 Process for preparation of pyridine derivatives NOX3, KMO, PBK CNR2 1053/4885TBK1 2091/4885SLC2A2 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback